British Journal of Dermatology · 2013 · 12 citations · 12 references
MedicineDermatologyOncologyCancer ImmunologyHematologic OncologyImmunopathologyCutaneous LymphomaImmunopathology Of SkinImmunosuppressionLymphoid NeoplasmsLymphoid Tissue PathologyChronic Myeloid Leukemia TherapyClonality ScreeningCutaneous T-cell Lymphoma ImmunopathologyCutaneous T-cell Lymphoma TreatmentMyeloid NeoplasmsT-cell Mediated Skin DiseaseT-cell Receptor Gene LociTransplant-associated Malignancy
We report on a patient who developed donor-derived cutaneous T-cell lymphoma (CTCL) 4 years after successful treatment of chronic myeloid leukaemia with an allogeneic bone marrow transplant. The patient developed an eczematous rash unresponsive to topical therapy and immunosuppression. When CTCL was diagnosed in the recipient, his sibling donor had been attending his local dermatology unit with a maculosquamous rash, which proved subsequently to be mycosis fungoides. An identical pattern of donor and recipient clonality assessment and T-cell receptor gene sequencing indicated that the CTCL was probably transmitted in the bone marrow harvest. This suggests that CTCL cells circulate in the marrow at an early subclinical stage in this disease. This is the second case of donor-derived CTCL reported to date.
12
Solid Cancers After Bone Marrow Transplantation
Andrew D. Louie, Ravi Bhatia, Margaret O’Donnell et al. · Journal of Clinical Oncology · 2001 · 315 citations
Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation
Hans‐Jochem Kolb, Gèrard Socié, Thomas Duell et al. · Annals of Internal Medicine · 1999 · 259 citations
Medicine, Hematology, Oncology +14